Business Description
Jyong Biotech Ltd., founded in 2002 and based in New Taipei City, Taiwan, focuses on turning plant-based compounds into approved medicines for urinary health conditions. The company is currently advancing three treatment candidates targeting benign prostate enlargement, prostate cancer, and bladder pain syndrome. Its products are being developed for patients in the United States, Europe, and Asia.
